Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Nanomedicine. 2010 Oct 1;7(2):193–200. doi: 10.1016/j.nano.2010.08.003

Figure 1.

Figure 1

Schematic representation of vector GHT composed of a GALA fusogenic peptide (FP), four repeating units of histone H2A (4HP), a cathepsin D substrate (CS), and a targeting motif (TM). The vector was genetically engineered in E.coli and purified. Reproduced with permission from [8].